News Quantified

SGMO – sangamo therapeutics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at WORLDSymposium™ 2026 [Yahoo! Finance]

Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at WORLDSymposium™ 2026

Sangamo Therapeutics Announces Pricing of $25.0 Million Underwritten Offering

Sangamo Therapeutics (NASDAQ:SGMO) was downgraded by analysts at Wall St

How The Pulled Price Target Is Reshaping The Story For Sangamo Therapeutics (SGMO) [Yahoo! Finance]

4.6%

MISS

-5.3%

MISS

-38.4%

MISS

-17.8%

MISS

Form 8-K SANGAMO THERAPEUTICS, For: Feb 03

Form 424B5 SANGAMO THERAPEUTICS,

Form 8-K SANGAMO THERAPEUTICS, For: Feb 03

Form FWP SANGAMO THERAPEUTICS, Filed by: SANGAMO THERAPEUTICS, INC

Form 8-K SANGAMO THERAPEUTICS, For: Feb 02

Top News Gainers

2/27 Biogen and Sangamo Announce Global Collaboration to Develop Gene Regulation Therapies for Alzheimer’s, Parkinson’s, Neuromuscular, and Other Neurological Diseases 33.3%

4/2 Form DEF 14A SANGAMO THERAPEUTICS, For: May 18 8.8%

4/17 Form 8-K SANGAMO THERAPEUTICS, For: Apr 13 8.6%

3/16 Sangamo's Partnership With Biogen Is Only One Big Pharma Partnership Based Off Of Pipeline [Seeking Alpha] 8.2%

3/18 Form 4 SANGAMO THERAPEUTICS, For: Mar 16 Filed by: DILLY STEPHEN GEORGE 7.5%

4/9 Sangamo Announces Closing of Biogen Collaboration Agreement 6.9%

12/23 Form 8-K SANGAMO THERAPEUTICS, For: Dec 17 6.4%

4/28 Form 4 SANGAMO THERAPEUTICS, For: Apr 25 Filed by: Duraibabu Prathyusha 6.0%

5/15 Sangamo Therapeutics Announces Presentations At Upcoming Scientific, Medical And Investor Conferences 5.9%

11/8 Sangamo Therapeutics Announces New Scientific Advisory Board 5.5%

Top News Decliners

3/14 Sangamo Therapeutics Inc (NASDAQ: SGMO) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -25.2%

12/9 Sangamo Therapeutics Inc (NASDAQ: SGMO) had its "buy" rating re-affirmed by analysts at Cowen Inc. -17.4%

5/8 Q1/2019 3/31/2019 EPS -0.410 ZacksConsensus -0.270 ActVsEst (0.140) - Miss -14.8%

2/28 Q4/2019 12/31/2019 EPS 0.040 ZacksConsensus -0.310 ActVsEst 0.350 - Beat -8.4%

8/7 Sangamo Therapeutics Reports Second Quarter 2019 Financial Results -6.1%

3/2 AbbVie Is A Notable Coronavirus Responder — But Is ABBV Stock A Buy? [Investor's Business Daily] -6.0%

4/21 Mogrify and Sangamo Announce Collaboration and Exclusive License Agreement for Mogrify’s iPSC- and ESC-Derived Regulatory T Cells -5.9%

4/2 Sangamo Therapeutics Inc (NASDAQ: SGMO) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -5.3%

1/25 Sangamo Therapeutics Inc (NASDAQ: SGMO) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -4.9%

9/30 Sangamo Therapeutics Appoints Bettina M. Cockroft, MD, MBA, as Senior Vice President and Chief Medical Officer -4.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day